Anti-Thyroid Drugs Market Forecast Showing Industry Progress And Growth Trends

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Anti-Thyroid Drugs Market Grow Between 2026 And 2030?

The anti-thyroid drugs market has experienced modest expansion recently. Its size is expected to increase from $2.49 billion in 2025 to $2.54 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 2.0%. The expansion observed historically can be linked to the significant occurrence of hyperthyroidism, the existence of oral treatment options, widespread diagnostic screening, well-developed endocrine medical services, and their application in radiation safety.

The anti-thyroid drugs market size is projected to experience consistent expansion over the upcoming years. It is predicted to reach $2.85 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 2.9%. This anticipated growth during the forecast period is attributable to an increase in autoimmune thyroid conditions, enhanced screening initiatives, improved access to healthcare services, advancements in thyroid regulation treatments, and an aging demographic. Key trends anticipated over the same period encompass a greater number of diagnosed thyroid disorders, the expanded application of thionamide-based medications, wider availability of outpatient thyroid care, more frequent monitoring of hormone concentrations, and advancements in drug safety profiles.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

Which Key Factors Are Driving The Anti-Thyroid Drugs Market Growth?

The expanding incidence of thyroid cancer is projected to fuel the expansion of the anti-thyroid drugs market moving forward. Thyroid cancer, a condition affecting the thyroid gland—located near the base of the throat and responsible for producing hormones that regulate various bodily functions like body temperature, heart rate, blood pressure, and weight—is becoming more common. This rise in prevalence is largely attributable to increased exposure to medical radiation and environmental carcinogens. Anti-thyroid drugs facilitate the early detection of thyroid cancer, which can significantly enhance treatment outcomes. As an illustration, data from August 2023, released by the American Society of Clinical Oncology, a US-based organization for oncologists and surgeons, indicated that in the United States, approximately 43,720 adults (comprising 12,540 men and 31,180 women) received a thyroid cancer diagnosis in 2023, with an estimated 2,120 deaths (970 men and 1,150 women) from the disease anticipated in the same year. Consequently, the increasing occurrence of thyroid cancer is driving the growth of the anti-thyroid drugs market.

How Are Segments Identified Within The Anti-Thyroid Drugs Market Segment Framework?

The anti-thyroid drugs market covered in this report is segmented –

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

Which Trends Are Shaping The Anti-Thyroid Drugs Market?

Major companies operating in the anti-thyroid drugs market are focusing on innovating products, such as monoclonal antibodies, to improve patient outcomes, reduce adverse effects, and strengthen their competitive position. Monoclonal antibodies refer to laboratory-engineered proteins that precisely target specific molecules in the body to help treat diseases more effectively. For instance, in March 2025, Innovent Biologics, Inc., a China-based biotechnology company, announced the approval of SYCUME, an anti-IGF-1R monoclonal antibody, by China’s National Medical Products Administration (NMPA) for the treatment of thyroid eye disease (TED). SYCUME is the first drug of its kind approved in China and the second worldwide, offering a new, effective treatment option that significantly reduces proptosis and inflammation while improving patients’ quality of life. The approval is based on positive clinical trial results demonstrating SYCUME’s ability to address the unmet needs of TED patients, providing a safer, more accessible alternative to existing therapies.

Who Are The Companies Competing Within The Anti-Thyroid Drugs Market?

Major companies operating in the anti-thyroid drugs market are Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., Pfizer Inc., Allergan plc, RLC LABS Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Aspen Pharmacare Holdings Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

Get The Full Anti-Thyroid Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Which Region Is The Leading Market For The Anti-Thyroid Drugs Market?

North America was the largest region in the anti-thyroid drugs market in 2025. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Anti-Thyroid Drugs Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Browse Through More Reports Similar to the Global Anti-Thyroid Drugs Market 2026, By The Business Research Company

Anti Thyroid Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

Thyroid Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report

Anti Infective Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795